{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:24:08Z","timestamp":1791897848930,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1208\/s12248-016-9979-x","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T16:49:08Z","timestamp":1473266948000},"page":"1562-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease"],"prefix":"10.1208","volume":"18","author":[{"given":"Yin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert A.","family":"Runnels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Khandke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Zlotnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Aulabaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Vidunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schlittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Stano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Dufield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin U","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"9979_CR1","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1473-3099(15)00217-0","volume":"15","author":"S Sridhar","year":"2015","unstructured":"Sridhar S, Greenwood B, Head C, Plotkin SA, S\u00e1fadi MA, Saha S, et al. Global incidence of serogroup B invasive meningococcal disease: a systematic review. Lancet Infect Dis. 2015;15:1334\u201346.","journal-title":"Lancet Infect Dis"},{"key":"9979_CR2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2003.10.005","volume":"22","author":"J Bruge","year":"2004","unstructured":"Bruge J, Bouveret-Le Cam N, Danve B, Rougon G, Schulz D. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers. Vaccine. 2004;22:1087\u201396.","journal-title":"Vaccine"},{"key":"9979_CR3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","volume":"126","author":"FA Wyle","year":"1972","unstructured":"Wyle FA, Artenstein MS, Brandt BL, Tramont EC, Kasper DL, Altieri PL. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis. 1972;126:514\u201321.","journal-title":"J Infect Dis"},{"key":"9979_CR4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","volume":"2","author":"J Finne","year":"1983","unstructured":"Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 1983;2:355\u20137.","journal-title":"Lancet"},{"key":"9979_CR5","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","volume":"27","author":"J Holst","year":"2009","unstructured":"Holst J, Martin D, Arnold R, Huergo CC, Oster P, O\u2019Hallahan J, et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine. 2009;27:B3\u201312.","journal-title":"Vaccine"},{"key":"9979_CR6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","volume":"281","author":"JW Tappero","year":"1999","unstructured":"Tappero JW, Lagos R, Maldonado Ballesteros A, Plikaytis B, Williams D, Dykes J, et al. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA. 1999;281:1520\u20137.","journal-title":"JAMA"},{"key":"9979_CR7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/14760584.2015.1016915","volume":"14","author":"KL Seib","year":"2015","unstructured":"Seib KL, Scarselli M, Comanducci M, Toneatto D, Masignani V. Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. Expert Rev Vaccines. 2015;14:841\u201359.","journal-title":"Expert Rev Vaccines"},{"key":"9979_CR8","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1016\/j.vaccine.2010.09.038","volume":"28","author":"DA Ala\u2019aldeen","year":"2010","unstructured":"Ala\u2019aldeen DA, Flint M, Oldfield NJ, Omer SA, McNeil LK, Jiang Q, et al. Human antibody responses to the meningococcal factor H binding protein (LP2086) during invasive disease, colonization and carriage. Vaccine. 2010;28:7667\u201375.","journal-title":"Vaccine"},{"key":"9979_CR9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","volume":"77","author":"KL Seib","year":"2009","unstructured":"Seib KL, Serruto D, Oriente F, Delany I, Adu-Bobie J, Veggi D, et al. Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. Infect Immun. 2009;77:292\u20139.","journal-title":"Infect Immun"},{"key":"9979_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","volume":"177","author":"G Madico","year":"2006","unstructured":"Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol. 2006;177:501\u201310.","journal-title":"J Immunol"},{"key":"9979_CR11","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","volume":"72","author":"LD Fletcher","year":"2004","unstructured":"Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, Knauf M, et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun. 2004;72:2088\u2013100.","journal-title":"Infect Immun"},{"key":"9979_CR12","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","volume":"28","author":"HQ Jiang","year":"2010","unstructured":"Jiang HQ, Hoiseth SK, Harris SL, McNeil LK, Zhu D, Tan C, et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine. 2010;28:6086\u201393.","journal-title":"Vaccine"},{"key":"9979_CR13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/INF.0b013e31829aa63b","volume":"32","author":"SK Hoiseth","year":"2013","unstructured":"Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, et al. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups. Pediatr Infect Dis J. 2013;32:1096\u2013101.","journal-title":"Pediatr Infect Dis J"},{"key":"9979_CR14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/MMBR.00056-12","volume":"77","author":"LK McNeil","year":"2013","unstructured":"McNeil LK, Zagursky RJ, Lin SL, Murphy E, Zlotnick GW, Hoiseth SK, et al. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev. 2013;77:234\u201352.","journal-title":"Microbiol Mol Biol Rev"},{"key":"9979_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.micro.61.080706.093245","volume":"61","author":"MP Bos","year":"2007","unstructured":"Bos MP, Robert V, Tommassen J. Biogenesis of the Gram-negative bacterial outer membrane. Ann Rev Microbiol. 2007;61:191\u2013214.","journal-title":"Ann Rev Microbiol"},{"key":"9979_CR16","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1074\/jbc.M808831200","volume":"284","author":"A Mascioni","year":"2009","unstructured":"Mascioni A, Bentley BE, Camarda R, Dilts DA, Fink P, Gusarova V, et al. Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J Biol Chem. 2009;284:8738\u201346.","journal-title":"J Biol Chem"},{"key":"9979_CR17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","volume":"78","author":"P Schuck","year":"2000","unstructured":"Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J. 2000;78:1606\u201319.","journal-title":"Biophys J"},{"key":"9979_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcatb.2009.11.010","volume":"62","author":"R Fernandez-Lafuente","year":"2010","unstructured":"Fernandez-Lafuente R. Lipase from Thermomyces lanuginosus: uses and prospects as an industrial biocatalyst. J Mol Cat B: Enzymatic. 2010;62:197\u2013212.","journal-title":"J Mol Cat B: Enzymatic"},{"key":"9979_CR19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","volume":"79","author":"KL Seib","year":"2011","unstructured":"Seib KL, Brunelli B, Brogioni B, Palumbo E, Bambini S, Muzzi A, et al. Characterisation of diverse sub-variants of the meningococcal factor H binding protein (fHbp) for their ability to bind fH, mediate serum resistance and induce bactericidal antibodies. Infect Immun. 2011;79:970\u201381.","journal-title":"Infect Immun"},{"key":"9979_CR20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1179\/096805102125001073","volume":"8","author":"K Takeda","year":"2002","unstructured":"Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res. 2002;8:459\u201363.","journal-title":"J Endotoxin Res"},{"key":"9979_CR21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/092986708783503249","volume":"16","author":"PM Moyle","year":"2008","unstructured":"Moyle PM, Toth I. Self-adjuvanting lipopeptide vaccines. Curr Med Chem. 2008;16:506\u201316.","journal-title":"Curr Med Chem"},{"key":"9979_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/156720105774370258","volume":"2","author":"LE Brown","year":"2005","unstructured":"Brown LE, Jackson DC. Lipid-based self-adjuvanting vaccines. Curr Drug Deliv. 2005;2:383\u201393.","journal-title":"Curr Drug Deliv"},{"key":"9979_CR23","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.137.8.2676","volume":"137","author":"A Lex","year":"1986","unstructured":"Lex A, Wiesm\u00fcller KH, Jung G, Bessler WG. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. J Immunol. 1986;137:2676\u201381.","journal-title":"J Immunol"},{"key":"9979_CR24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","volume":"458","author":"MC Schneider","year":"2009","unstructured":"Schneider MC, Prosser BE, Caesar JJE, Kugelberg E, Li S, Zhang Q, et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature. 2009;458:890\u20133.","journal-title":"Nature"},{"key":"9979_CR25","doi-asserted-by":"crossref","first-page":"e1002981","DOI":"10.1371\/journal.ppat.1002981","volume":"8","author":"S Johnson","year":"2012","unstructured":"Johnson S, Tan L, van der Veen S, Caesar J, Goicoechea De Jorge E, Harding RJ, et al. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLOS Pathogens. 2012;8:e1002981.","journal-title":"PLOS Pathogens"},{"key":"9979_CR26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","volume":"200","author":"E Murphy","year":"2009","unstructured":"Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, Fink PS, et al. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis. 2009;200:379\u201389.","journal-title":"J Infect Dis"},{"key":"9979_CR27","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/pmic.201000688","volume":"11","author":"Y Kwok","year":"2011","unstructured":"Kwok Y, Sung W-C, Lin AL-H, Liu H-H, Chou FA-H, Hsieh SS-Y, et al. Rapid isolation and characterization of bacterial lipopeptides using liquid chromatography and mass spectrometry analysis. Proteomics. 2011;11:2620\u20137.","journal-title":"Proteomics"},{"key":"9979_CR28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/anie.198508721","volume":"24","author":"G Jung","year":"1985","unstructured":"Jung G, Wiesmuller K-H, Becker G, Buhring H-J, Bessler WG. Increased production of specific antibodies by presentation of the antigen determinants with covalently coupled lipopeptide mitogens. Angew Chem Int Ed Engl. 1985;24:872\u20133.","journal-title":"Angew Chem Int Ed Engl"},{"key":"9979_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0264-410X(89)90007-8","volume":"7","author":"K-H Wiesm\u00fcller","year":"1989","unstructured":"Wiesm\u00fcller K-H, Jung G, Hess G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine. 1989;7:29\u201333.","journal-title":"Vaccine"},{"key":"9979_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/342561a0","volume":"342","author":"K Deres","year":"1989","unstructured":"Deres K, Schild H, Wiesmuller K-H, Jung G, Rammensee H-G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature. 1989;342:561\u20134.","journal-title":"Nature"},{"key":"9979_CR31","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1016\/j.vaccine.2010.09.024","volume":"28","author":"LE Brown","year":"2010","unstructured":"Brown LE. The role of adjuvants in vaccines for seasonal and pandemic influenza. Vaccine. 2010;28:8043\u20135.","journal-title":"Vaccine"},{"key":"9979_CR32","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/j.vaccine.2008.09.045","volume":"26","author":"A Lahiri","year":"2008","unstructured":"Lahiri A, Das P, Chakravortty D. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine. 2008;26:6777\u201383.","journal-title":"Vaccine"},{"key":"9979_CR33","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.vaccine.2008.03.032","volume":"26","author":"BY Chua","year":"2008","unstructured":"Chua BY, Eriksson EM, Brown LE, Zeng W, Gowans EJ, Torresi J, et al. A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection. Vaccine. 2008;26:4866\u201375.","journal-title":"Vaccine"},{"key":"9979_CR34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.171.1.32","volume":"171","author":"KW Schjetne","year":"2003","unstructured":"Schjetne KW, Thompson KM, Nilsen N, Flo TH, Fleckenstein B, Versen JG, et al. Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J Immunol. 2003;171:32\u20136.","journal-title":"J Immunol"},{"key":"9979_CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","volume":"91","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov R, Janeway CAJ. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997;91:295\u20138.","journal-title":"Cell"},{"key":"9979_CR36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","volume":"130","author":"MS Jin","year":"2007","unstructured":"Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik S-G, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007;130:1071\u201382.","journal-title":"Cell"},{"key":"9979_CR37","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.immuni.2009.09.018","volume":"31","author":"JY Kang","year":"2009","unstructured":"Kang JY, Nan X, Jin MS, Youn S-J, Ryu YH, Mah S, et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity. 2009;31:873\u201384.","journal-title":"Immunity"},{"key":"9979_CR38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1189\/jlb.69.3.474","volume":"69","author":"TH Flo","year":"2001","unstructured":"Flo TH, Halaas \u00d8, Torp S, Ryan L, Lien E, Dybdahl B, et al. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol. 2001;69:474\u201381.","journal-title":"J Leukoc Biol"},{"key":"9979_CR39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-642-02309-5_7","volume-title":"Natural killer cells","author":"BP McSharry","year":"2010","unstructured":"McSharry BP, Gardiner CM. The role of NK cells in bacterial infections. In: Zimmer J, editor. Natural killer cells. Berlin: Springer; 2010. p. 153\u201375."},{"key":"9979_CR40","doi-asserted-by":"crossref","unstructured":"MacLeod H, Wetzler LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE. 2007;2007:pe48.","DOI":"10.1126\/stke.4022007pe48"},{"key":"9979_CR41","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1111\/j.1742-4658.2005.05029.x","volume":"272","author":"U Buwitt-Beckmann","year":"2005","unstructured":"Buwitt-Beckmann U, Heine H, Wiesmuller K-H, Jung G, Brock R, Ulmer AJ. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J. 2005;272:6354\u201364.","journal-title":"FEBS J"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-016-9979-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-9979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:18:02Z","timestamp":1692490682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-016-9979-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9979"],"URL":"https:\/\/doi.org\/10.1208\/s12248-016-9979-x","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}